Colorectal Cancer
FDA Oks ColoSense, a Stool Test for Early Colorectal Cancer Detection
The FDA has approved ColoSense, a stool screening test with 93% accuracy for colon cancer in average-risk adults over the age of 45. This noninvasive option may boost early detection rates.
Read More
Behind the FDA Approval of Fruquintinib for Previously Treated mCRC
In season 4, episode 18 of Targeted Talks, Arvind Dasari, MD, MS, dives into the recent approval of fruquintinib for patients with metastatic colorectal cancer.
Listen
Personalized Vaccine Shows Early Promise in Metastatic Colorectal Cancer
A phase 2/3 study of GRANITE vaccine in combination with standard therapy shows encouraging early signs of efficacy and safety in patients with metastatic microsatellite-stable colorectal cancer.
Special Episode: Insight on Targeting Rare Genomic Alterations in Colorectal Cancers
In season 2, episode 6 of Targeted Talks, Dr. Michael J. Overman, joins Targeted Oncology for a special discussion around rare genomic alterations in colorectal cancer
Colorectal Cancer: Leveraging Awareness and Early Detection
For Colorectal Cancer Awareness Month, Jedrzej Wykretowicz, MD, PhD, discussed the importance of early detection and taking steps towards the prevention of colorectal cancer.
FDA Grants Orphan Drug Designation to Novel CAR T-Cell Therapy in Colorectal Cancer
The novel cell therapy A2B530 is the first logic-gated cell therapy aimed at selectively killing tumor cells and protecting healthy cells in colorectal cancer.